Afimmune
Manufacturing · Ireland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Dublin, Dublin City, IrelandPhone Number
+353 12946380Website
www.afimmune.comRevenue
$6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Afimmune
Afimmune is a privately held drug discovery and development company based in Dublin, Ireland, focused on pioneering treatments for rare and cardiometabolic diseases, particularly Sickle Cell Disease. They are developing bioactive lipids and have assets in various stages of clinical and pre-clinical development. The company's goal is to improve the quality of life for patients suffering from rare and inflammatory diseases. Afimmune's innovations include the Epeleuton platform, which has garnered attention for its potential in addressing these medical challenges.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Afimmune your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Afimmune launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if Afimmune has recently received funding, and reach out quickly before it becomes old news!
Afimmune, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Afimmune had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Afimmune has new funding data
Earning: See what the market has to say on Afimmune recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Afimmune
Check out if Afimmune is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Afimmune as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Afimmune is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Afimmune is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Afimmune.
Afimmune Tech Stack
A closer look at the technologies used by Afimmune
See more technologies
Afimmune News & Media
Afimmune to present at American Society of Hematology (ASH) after initiating recruitment in Sickle Cell Disease trial
Afimmune to present trial design at the American Society of Hematology (ASH) Annual Meeting after initiating recruitment in first Sickle Cell Disease trial DUBLIN, IRELAND, November 8, 2023 /EINPresswire.com/ -- Afimmune, a clinical stage …L'Epeleuton d'Afimmune contribue à une réduction majeure de la charge virale et à des changements pathologiques selon une étude sur la COVID-19
DUBLIN--(BUSINESS WIRE)--Afimmune, une société de stade clinique axée sur le développement de lipides bioactifs pour le traitement des maladies inflammatoires et cardiométaboliques, a présenté aujourd'hui les principaux résultats obtenus avec l’Epeleuton dans une étude utilisant un modèle hamster bien établi pour l'infection par le SRAS-CoV-2. L'Epeleuton a déjà démontré des effets anti-inflammatoires et métaboliques positifs dans des essais cliniques de phase II réalisés sur des patients et meAfimmune-Präparat Epeleuton zeigt in COVID-19-Studie starken Rückgang von Viruslast und pathologischen Veränderungen
DUBLIN--(BUSINESS WIRE)--Afimmune, ein in der klinischen Phase tätiges Arzneimittelforschungsunternehmen, das sich auf die Entwicklung biologisch aktiver Lipide zur Behandlung von Entzündungs- und kardiometabolischen Erkrankungen konzentriert, veröffentlichte heute wichtige Ergebnisse mit Epeleuton in einem gut etablierten Hamstermodell für die SARS-CoV-2-Infektion. Epeleuton hat bereits in klinischen Phase-2-Studien, die vom Unternehmen an Patienten durchgeführt wurden, entzündungshemmende undRiassunto: Epeleuton di Afimmune dimostra importanti abbattimenti della carica batterica e cambiamenti patologici in uno studio sul COVID-19
DUBLINO--(BUSINESS WIRE)--Afimmune, società di scoperta farmacologica di fase clinica focalizzata sullo sviluppo di lipidi biologicamente attivi per il trattamento di patologie infiammatorie e cardiometaboliche, oggi annuncia importanti risultati su Epeleuton in un comprovato modello sui criceti per l'infezione da SARS-CoV-2. Epeleuton ha già dimostrato effetti antinfiammatori e metabolici positivi nel corso di studi clinici tra pazienti (di fase 2) condotti dall'azienda. Epeleuton, a dosi clin
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Afimmune
Sign Up For FreeTo access detailed company insights
Afimmune is a privately held drug discovery and development company based in Dublin, Ireland, focused on pioneering treatments for rare and cardiometabolic diseases, particularly Sickle Cell Disease. They are developing bioactive lipids and have assets in various stages of clinical and pre-clinical development. The company's goal is to improve the... Read More
